Panagora Asset Management’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-637
Closed -$14K 2596
2019
Q2
$14K Sell
637
-23
-3% -$677 ﹤0.01% 2349
2019
Q1
$20K Buy
660
+641
+3,374% +$19.7K ﹤0.01% 2254
2018
Q4
$1K Buy
19
+9
+90% +$274 ﹤0.01% 2427
2018
Q3
$0 Buy
+10
New +$302 ﹤0.01% 2455
2017
Q3
Sell
-3,021
Closed -$63K 2458
2017
Q2
$63K Buy
+3,021
New +$60.6K ﹤0.01% 2014

Other funds holding PRPH

Panagora Asset Management's PRPH Position: Q3 2019 in Review

Panagora Asset Management sold out of ProPhase Labs (PRPH) in Q3 2019, closing a stake of 637 shares — an estimated $14K sold.

Panagora Asset Management first reported a position in PRPH in Q2 2017 and held it in 5 quarters. The position peaked at $63K in Q2 2017. 14 funds tracked by Wall St. Rank hold PRPH as of Q3 2019.

  • Panagora Asset Management reported no remaining ProPhase Labs position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 637 ProPhase Labs shares in Q3 2019, an estimated $14K.
  • Panagora Asset Management first reported a position in ProPhase Labs in Q2 2017 and held it in 5 quarters.
  • Panagora Asset Management's ProPhase Labs position peaked at $63K in Q2 2017.
  • 14 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.